May 30, 2024 -- Nippon Express Europe GmbH (President: Shinichi Kakiyama; hereinafter "NX Europe"), a group company of NIPPON EXPRESS HOLDINGS, INC. (President: Satoshi Horikiri), took part in LogiPharma2024 held in Lyon, France from Tuesday, April 16 to Thursday, April 18.
LogiPharma is one of Europe's largest international pharmaceutical trade shows, focusing on issues, trends and the latest technologies in pharmaceutical and biopharmaceutical supply chains.
The exhibition attracted approximately 2,000 participants from a variety of companies involved in the manufacturing and distribution of pharmaceuticals, including pharmaceutical and biopharmaceutical companies, medical device manufacturers, and logistics firms.
This was NX Europe's second consecutive year participating in the exhibition. Our NX Healthcare team introduced the NX Group's global network of Good Distribution Practice (GDP) certified business locations and its high-quality transport and storage services offering our variety of temperature control solutions tailored to pharmaceutical distribution processes. Our experts also discussed and presented NX Group's ambitious sustainability roadmap tailored to pharmaceutical supply chain solutions.
Questions around this news
What is LogiPharma?
LogiPharma is an industry event focused on the supply chains that support pharmaceutical and biopharmaceutical products. It brings together organizations involved in areas such as manufacturing, distribution, logistics, and medical devices to discuss supply-chain challenges, developments, and technologies.
What did NX Europe present at LogiPharma 2024?
The company introduced the NX Group’s global network of locations certified for Good Distribution Practice and described transport and storage services with temperature-control options for pharmaceutical distribution. Its experts also discussed the group’s sustainability roadmap for pharmaceutical supply-chain solutions.
What does Good Distribution Practice mean in pharmaceutical logistics?
Good Distribution Practice, or GDP, refers to quality standards and procedures for storing and distributing medicinal products. Its purpose is to help preserve product quality and prevent issues such as contamination, damage, or unsuitable handling as products move through the supply chain.
Why is temperature control important when transporting pharmaceuticals?
Some medicines and biological products can be affected by exposure to temperatures outside their required ranges. Temperature-controlled transport and storage help maintain appropriate conditions during handling and transit. The specific requirements depend on the product, so logistics processes are designed around its needs.
What are the NX Group’s plans for pharmaceutical logistics?
The release says the NX Group intends to expand its pharmaceutical logistics services and strengthen its global efforts in the pharmaceutical industry. It identifies pharmaceuticals as a priority industry in the group’s business plan but does not provide further details about the expansion or its timing.
The NX Group will continue expanding its pharmaceutical logistics services and strengthening its global efforts in the pharmaceutical industry, which has been positioned as a priority industry in the Group's business plan.
If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.
At a glance
- Company
- Nippon Express Europe GmbH
- Announcement
- Event
- Location
- Lyon, France
Key figures
- LogiPharma participants
- approximately 2,000
- Consecutive years participating
- second
People
- Shinichi KakiyamaPresident, Nippon Express Europe GmbH
- Satoshi HorikiriPresident, NIPPON EXPRESS HOLDINGS, INC.
